Alector, Inc.
NASDAQ: ALEC. Canonical company identity and public leadership record.
US
- Alpha ID
- alpha:company:96497620-d082-4075-9fcf-c3128fd571e7
- SEC CIK
- 0001653087
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 18, 2026
- Newest evidence
- Apr 28, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Arnon Rosenthal, Ph.D.Since Apr 28, 2026
- Chair
- Not published
- Independent
- 7 / 99 directors published
- Published claims
- 163 distinct sources
- Evidence records
- 50 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 5 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
CEO CHANGED
Arnon Rosenthal, Ph.D. executive of Alector, Inc., effective 2026-04-28.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Co-founder and Chief Executive Officer | Arnon Rosenthal, Ph.D. | Apr 2026 | current | Source reportedE3 |
| Chief Financial Officer and Chief Business Officer | Neil Berkley | Apr 2026 | current | Source reportedE4 |
| President and Head of Research and Development | Sara Kenkare-Mitra, Ph.D. | Apr 2026 | current | Source reportedE5 |
Board of directors
Evidence9 directors published. 7 of 9 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Arnon Rosenthal, Ph.D. | Not independent | 2013 | None published | Source reportedE2 |
| David Wehner | Independent | 2018 | None published | Source reportedE2 |
| Elizabeth Garofalo, M.D. | Independent | 2021 | None published | Source reportedE2 |
| Errol De Souza, Ph.D. | Independent | 2024 | None published | Source reportedE2 |
| Kristine Yaffe, M.D. | Independent | 2019 | None published | Source reportedE2 |
| Louis J. Lavigne, Jr. | Independent | 2018 | None published | Source reportedE2 |
| Mark Altmeyer | Independent | 2024 | None published | Source reportedE2 |
| Paula Hammond, Ph.D. | Independent | 2020 | None published | Source reportedE2 |
| Richard H. Scheller, Ph.D. | Not independent | 2018 | None published | Source reportedE2 |
Committees and risk ownership
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
EvidenceGovernance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- CommitteesNot reviewed. Committee mandates show where oversight is delegated.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Arnon Rosenthal, Ph.D.Co-founder and Chief Executive Officercompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:14
- Neil BerkleyChief Financial Officer and Chief Business Officercompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:15
- Sara Kenkare-Mitra, Ph.D.President and Head of Research and Developmentcompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:16
- Arnon Rosenthal, Ph.D.Directorcompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:5
- David WehnerDirectorcompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:6
- Elizabeth Garofalo, M.D.Directorcompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:7
- Errol De Souza, Ph.D.Directorcompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:8
- Kristine Yaffe, M.D.Directorcompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:9
- Louis J. Lavigne, Jr.Directorcompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:10
- Mark AltmeyerDirectorcompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:11
- Paula Hammond, Ph.D.Directorcompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:12
- Richard H. Scheller, Ph.D.Directorcompany:96497620-d082-4075-9fcf-c3128fd571e7:leadership_role:13
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 5 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 18, 2026. Cited by 4 Claims.
- E2sec proxy. Published Apr 24, 2025. Retrieved Apr 24, 2026. Cited by 9 Claims.
- E3sec filing. Published Apr 28, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E4sec filing. Published Apr 28, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E5sec filing. Published Apr 28, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 18, 2026- Arnon Rosenthal, Ph.D. executive of Alector, Inc., effective 2026-04-28.
- Neil Berkley executive of Alector, Inc., effective 2026-04-28.
- Sara Kenkare-Mitra, Ph.D. executive of Alector, Inc., effective 2026-04-28.
- Errol De Souza, Ph.D. seat on Alector, Inc., effective 2024-01-01.
- Mark Altmeyer seat on Alector, Inc., effective 2024-01-01.
- Elizabeth Garofalo, M.D. seat on Alector, Inc., effective 2021-01-01.
- Paula Hammond, Ph.D. seat on Alector, Inc., effective 2020-01-01.
- Kristine Yaffe, M.D. seat on Alector, Inc., effective 2019-01-01.
- David Wehner seat on Alector, Inc., effective 2018-01-01.
- Louis J. Lavigne, Jr. seat on Alector, Inc., effective 2018-01-01.
- Richard H. Scheller, Ph.D. seat on Alector, Inc., effective 2018-01-01.
- Arnon Rosenthal, Ph.D. seat on Alector, Inc., effective 2013-01-01.

